Literature DB >> 29908347

Aging related functional and structural changes in the heart and aorta: MitoTEMPO improves aged-cardiovascular performance.

Yusuf Olgar1, Sinan Degirmenci1, Aysegul Durak1, Deniz Billur2, Belgin Can2, Gizem Kayki-Mutlu3, Ebru Arioglu-Inan3, Belma Turan4.   

Abstract

Aging in humans represents declining in cardio-protective systems, however its mechanisms are not known yet. We aimed to analyse how aging affects key mechanisms responsible for contractile dysfunction via comparing the improperly synchrony between electrical and mechanical activities in male aged-rats (24-month old) comparison to those of adult-rats (6-month old). We determined significantly increased systemic oxidative stress with decreased antioxidant capacity, clear insulin resistance and hypertrophy in aged-rats with normal fasting blood glucose. We also determined significantly high level of reactive oxygen species, ROS production in fluorescent dye chloromethyl-2',7'-dichlorodihydrofluoroscein diacetate (DCFDA) loaded isolated cardiomyocytes from aged-rats, confirming the increased oxidative stress in these hearts. In situ electrocardiograms, ECGs presented significant prolongations in RR- and QT-intervals in the aged-rats. Invasive hemodynamic measurements demonstrated marked increases in the heart rate and mean arterial pressure and decreases in the ejection-fraction and preload-recruitable stroke-work, together with depressed contraction and relaxation activities in aortic rings. In light and electron microscopy examinations in aged-rats, significant increases in muscle fibre radius and amount of collagen fibres were detected in the heart as well as markedly flattened and partial local splitting in elastic lamellas in the aorta, besides irregularly clustered mitochondria and lysosomes around the myofilaments in cardiomyocytes. MitoTEMPO treatment of tissue samples and cardiomyocytes from aged-rats for 1-h induced significant structural improvements. In the second part of our study, we have shown that mitochondria-targeted antioxidant MitoTEMPO antagonized all alterations in the heart samples as well as penylephrine-induced contractile and acetylcholine-induced relaxation responses of aged-rat aortic rings. Overall, the present data strongly support the important role of mitochondrial oxidative stress in the development of aged-related insufficiencies and that antioxidant strategies specifically targeting this organelle could have therapeutic benefit in aging-associated complications.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging-heart; Cardiovascular function; Insulin resistance; Mitochondria; Oxidative stress; Reactive oxygen species

Mesh:

Substances:

Year:  2018        PMID: 29908347     DOI: 10.1016/j.exger.2018.06.012

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  16 in total

Review 1.  As time flies by: Investigating cardiac aging in the short-lived Drosophila model.

Authors:  Anna C Blice-Baum; Maria Clara Guida; Paul S Hartley; Peter D Adams; Rolf Bodmer; Anthony Cammarato
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-11-27       Impact factor: 5.187

Review 2.  Mitochondria-targeted senotherapeutic interventions.

Authors:  Mehmet Can Atayik; Ufuk Çakatay
Journal:  Biogerontology       Date:  2022-07-04       Impact factor: 4.284

Review 3.  Interplay between Zn2+ Homeostasis and Mitochondrial Functions in Cardiovascular Diseases and Heart Ageing.

Authors:  Siarhei A Dabravolski; Nikolay K Sadykhov; Andrey G Kartuesov; Evgeny E Borisov; Vasily N Sukhorukov; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

Review 4.  The role of labile Zn2+ and Zn2+-transporters in the pathophysiology of mitochondria dysfunction in cardiomyocytes.

Authors:  Belma Turan; Erkan Tuncay
Journal:  Mol Cell Biochem       Date:  2020-11-22       Impact factor: 3.396

5.  Increased protein S-nitrosylation in mitochondria: a key mechanism of exercise-induced cardioprotection.

Authors:  Doria Boulghobra; Mathilde Dubois; Béatrice Alpha-Bazin; Florence Coste; Maxime Olmos; Sandrine Gayrard; Isabelle Bornard; Gregory Meyer; Jean-Charles Gaillard; Jean Armengaud; Cyril Reboul
Journal:  Basic Res Cardiol       Date:  2021-12-23       Impact factor: 17.165

Review 6.  Aging-Induced Impairment of Vascular Function: Mitochondrial Redox Contributions and Physiological/Clinical Implications.

Authors:  Evan Paul Tracy; William Hughes; Jason E Beare; Gabrielle Rowe; Andreas Beyer; Amanda Jo LeBlanc
Journal:  Antioxid Redox Signal       Date:  2021-09-17       Impact factor: 7.468

7.  A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats.

Authors:  Aysegul Durak; Yusuf Olgar; Sinan Degirmenci; Erman Akkus; Erkan Tuncay; Belma Turan
Journal:  Cardiovasc Diabetol       Date:  2018-11-17       Impact factor: 9.951

8.  Heart Histopathology and Mitochondrial Ultrastructure in Aged Rats Fed for 24 Months on Different Unsaturated Fats (Virgin Olive Oil, Sunflower Oil or Fish Oil) and Affected by Different Longevity.

Authors:  María D Navarro-Hortal; César L Ramírez-Tortosa; Alfonso Varela-López; José M Romero-Márquez; Julio J Ochoa; MCarmen Ramírez-Tortosa; Tamara Y Forbes-Hernández; Sergio Granados-Principal; Maurizio Battino; José L Quiles
Journal:  Nutrients       Date:  2019-10-07       Impact factor: 5.717

9.  Azoramide improves mitochondrial dysfunction in palmitate-induced insulin resistant H9c2 cells.

Authors:  Esma Nur Okatan; Yusuf Olgar; Erkan Tuncay; Belma Turan
Journal:  Mol Cell Biochem       Date:  2019-07-20       Impact factor: 3.842

Review 10.  Age-Related Deterioration of Mitochondrial Function in the Intestine.

Authors:  Anna M Schneider; Mihriban Özsoy; Franz A Zimmermann; René G Feichtinger; Johannes A Mayr; Barbara Kofler; Wolfgang Sperl; Daniel Weghuber; Katharina Mörwald
Journal:  Oxid Med Cell Longev       Date:  2020-08-18       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.